Published in Nat Commun on January 01, 2013
Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest (2014) 1.77
Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology (2014) 1.73
Pathobiology of liver fibrosis: a translational success story. Gut (2015) 1.72
Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A (2014) 1.71
Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology (2015) 1.68
Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep (2014) 1.58
BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci U S A (2015) 1.51
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape. J Hepatol (2015) 1.49
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. Cancer Cell (2016) 1.47
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol (2015) 1.46
Healing scars: targeting pericytes to treat fibrosis. QJM (2014) 1.42
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab (2016) 1.39
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35
Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol (2015) 1.24
Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci (2015) 1.05
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. Nat Commun (2014) 1.05
High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc (2015) 1.03
Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol (2015) 1.01
The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol (2014) 1.01
Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology (2014) 0.99
Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. J Hepatol (2016) 0.98
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest (2015) 0.95
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. Int J Mol Sci (2014) 0.95
The portal fibroblast: not just a poor man's stellate cell. Gastroenterology (2014) 0.93
Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond) (2015) 0.92
Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther (2014) 0.91
Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology (2014) 0.91
It has to be the αv: myofibroblast integrins activate latent TGF-β1. Nat Med (2013) 0.90
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr (2014) 0.89
Liver: hepatic stellate cells hold the key to liver fibrosis. Nat Rev Gastroenterol Hepatol (2013) 0.89
The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration. Gut Liver (2016) 0.88
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis. Cell Stem Cell (2016) 0.88
Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr (2014) 0.88
Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex. J Immunol (2015) 0.88
Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol (2015) 0.86
β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J Hepatol (2015) 0.86
Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res (2014) 0.86
Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease. Gastroenterology (2015) 0.85
Promising Therapy Candidates for Liver Fibrosis. Front Physiol (2016) 0.85
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology (2015) 0.85
Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation. Sci Rep (2016) 0.84
Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. J Pathol (2016) 0.84
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology (2015) 0.84
Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies. Curr Pathobiol Rep (2014) 0.84
The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Front Physiol (2015) 0.84
Cre-ativity in the liver: transgenic approaches to targeting hepatic nonparenchymal cells. Hepatology (2015) 0.84
Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol (2014) 0.83
CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism. Gut (2015) 0.83
Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis. J Clin Med (2016) 0.82
The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice. Hepatology (2015) 0.82
Establishment and characterization of rat portal myofibroblast cell lines. PLoS One (2015) 0.82
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun (2016) 0.81
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep (2016) 0.81
The plastic liver: differentiated cells, stem cells, every cell? J Clin Invest (2014) 0.81
Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Med (2016) 0.81
Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells. PLoS One (2016) 0.80
Role of hemostatic factors in hepatic injury and disease: animal models de-liver. J Thromb Haemost (2016) 0.80
Hepatic Stellate Cell-Derived Microvesicles Prevent Hepatocytes from Injury Induced by APAP/H2O2. Stem Cells Int (2016) 0.80
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease. J Autoimmun (2015) 0.80
Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res (2016) 0.79
In vitro reversion of activated primary human hepatic stellate cells. Fibrogenesis Tissue Repair (2015) 0.79
Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts. Front Physiol (2015) 0.79
DGAT1-deficiency affects the cellular distribution of hepatic retinoid and attenuates the progression of CCl4-induced liver fibrosis. Hepatobiliary Surg Nutr (2015) 0.79
Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein. Hepatology (2015) 0.78
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells. Oncotarget (2015) 0.78
Reversibility and heritability of liver fibrosis: Implications for research and therapy. World J Gastroenterol (2015) 0.78
Bone marrow-derived fibrocytes contribute to liver fibrosis. Exp Biol Med (Maywood) (2015) 0.78
Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role? Medicine (Baltimore) (2015) 0.78
The origin of fibrogenic myofibroblasts in fibrotic liver. Hepatology (2016) 0.78
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice. BMC Syst Biol (2015) 0.77
Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis. Sci Rep (2017) 0.77
The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury. Sci Rep (2016) 0.77
Role of CTGF gene promoter methylation in the development of hepatic fibrosis. Am J Transl Res (2016) 0.77
Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment. Stem Cell Reports (2016) 0.77
Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice. PLoS One (2016) 0.77
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice. PLoS One (2016) 0.77
Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Sci Rep (2016) 0.77
Advances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin. Stem Cells Int (2015) 0.77
Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via αv integrin interaction. J Gastroenterol (2016) 0.77
Expression of mediators of purinergic signaling in human liver cell lines. Purinergic Signal (2014) 0.77
Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis. Front Physiol (2015) 0.77
Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts. Front Physiol (2015) 0.77
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis. F1000Res (2016) 0.76
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice. Toxicol Appl Pharmacol (2016) 0.76
A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo. J Hepatol (2016) 0.76
Isolation and time lapse microscopy of highly pure hepatic stellate cells. Anal Cell Pathol (Amst) (2015) 0.76
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J Clin Transl Hepatol (2015) 0.76
Beyond scar formation: portal myofibroblast-mediated angiogenesis in the fibrotic liver. Hepatology (2015) 0.76
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nat Commun (2016) 0.76
Induction and contribution of beta platelet-derived growth factor signalling by hepatic stellate cells to liver regeneration after partial hepatectomy in mice. Liver Int (2015) 0.76
Angiogenesis and Fibrogenesis in Chronic Liver Diseases. Cell Mol Gastroenterol Hepatol (2015) 0.76
Integrins, myofibroblasts, and organ fibrosis. Hepatology (2014) 0.76
Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis. Free Radic Biol Med (2015) 0.76
Portal Fibroblasts in Biliary Fibrosis. Curr Pathobiol Rep (2014) 0.76
MBSJ MCC Young Scientist Award 2012 Liver regeneration: a unique and flexible reaction depending on the type of injury. Genes Cells (2014) 0.76
Aryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis. Biomed Res Int (2016) 0.76
Origin of fibrosing cells in systemic sclerosis. Curr Opin Rheumatol (2015) 0.75
Hepatic myofibroblasts derived from Schistosoma mansoni-infected mice are a source of IL-5 and eotaxin: controls of eosinophil populations in vitro. Parasit Vectors (2015) 0.75
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin. J Biol Chem (2016) 0.75
Experimental Model for Successful Liver Cell Therapy by Lenti TTR-YapERT2 Transduced Hepatocytes with Tamoxifen Control of Yap Subcellular Location. Sci Rep (2016) 0.75
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94
A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86
Liver fibrosis. J Clin Invest (2005) 17.27
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med (2007) 9.77
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol (2009) 7.34
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis (2001) 6.29
The myofibroblast in wound healing and fibrocontractive diseases. J Pathol (2003) 6.16
Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell (2011) 6.12
GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci (2004) 5.92
A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods (2005) 5.59
Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell (2012) 4.98
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A (1985) 4.76
Origin and function of myofibroblasts in kidney fibrosis. Nat Med (2013) 4.55
Generation and regeneration of cells of the liver and pancreas. Science (2008) 4.21
A pericyte origin of spinal cord scar tissue. Science (2011) 4.12
Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology (2007) 4.06
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc (2008) 4.02
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A (2012) 3.90
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A (2011) 3.82
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol (2006) 3.42
Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology (2012) 3.34
Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology (2012) 3.19
Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J Biol Chem (2003) 3.16
Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology (2010) 3.10
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest (2011) 2.83
Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology (2010) 2.73
Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med (2013) 2.72
Evolving therapies for liver fibrosis. J Clin Invest (2013) 2.59
The bone marrow functionally contributes to liver fibrosis. Gastroenterology (2006) 2.52
Non-cell-autonomous tumor suppression by p53. Cell (2013) 2.40
Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology (2011) 2.37
Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells (2008) 2.24
Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology (2012) 2.11
DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology (2003) 2.10
Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology (2009) 2.06
Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology (2010) 1.97
Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology (2011) 1.95
Smoothened is a master regulator of adult liver repair. J Clin Invest (2013) 1.89
Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta (2008) 1.89
Scraping fibrosis: expressway to the core of fibrosis. Nat Med (2011) 1.82
Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med (2013) 1.67
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol (2005) 1.62
Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci U S A (2013) 1.59
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol (2012) 1.50
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis (2007) 1.42
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology (2013) 1.40
Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut (2011) 1.39
Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J Hepatol (2005) 1.34
Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol (2013) 1.28
Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. J Biol Chem (2006) 1.16
Anti-fibrotic therapy: lost in translation? J Hepatol (2012) 1.12
Lecithin: retinol acyltransferase protein is distributed in both hepatic stellate cells and endothelial cells of normal rodent and human liver. Liver Int (2008) 0.89
Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis (2010) 1.13
High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab (2014) 1.12
Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta (2012) 0.99